StocksFundsScreenerSectorsWatchlists
FONR

FONR - FONAR Corp Stock Price, Fair Value and News

21.50USD-0.29 (-1.33%)Delayed as of 28 Mar 2024, 01:45 pm ET

Market Summary

FONR
USD21.50-0.29
Delayedas of 28 Mar 2024, 01:45 pm
-1.33%

FONR Stock Price

View Fullscreen

FONR RSI Chart

FONR Valuation

Market Cap

140.5M

Price/Earnings (Trailing)

10.84

Price/Sales (Trailing)

1.37

EV/EBITDA

3.92

Price/Free Cashflow

11.47

FONR Price/Sales (Trailing)

FONR Profitability

EBT Margin

19.96%

Return on Equity

7.91%

Return on Assets

6.41%

Free Cashflow Yield

8.72%

FONR Fundamentals

FONR Revenue

Revenue (TTM)

102.4M

Rev. Growth (Yr)

4.66%

Rev. Growth (Qtr)

-1.75%

FONR Earnings

Earnings (TTM)

13.0M

Earnings Growth (Yr)

68.41%

Earnings Growth (Qtr)

-8.45%

Breaking Down FONR Revenue

52 Week Range

14.5821.71
(Low)(High)

Last 7 days

1.8%

Last 30 days

-3.3%

Last 90 days

12.0%

Trailing 12 Months

35.1%

How does FONR drawdown profile look like?

FONR Financial Health

Current Ratio

9.35

Debt/Equity

6e-4

Debt/Cashflow

166.24

FONR Investor Care

Buy Backs (1Y)

1.32%

Diluted EPS (TTM)

1.77

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202397.7M98.6M101.3M102.4M
202297.5M97.6M97.1M96.8M
202186.0M89.9M92.7M96.0M
202087.4M85.7M84.9M84.6M
201985.7M87.2M88.2M88.5M
201881.4M81.5M82.9M83.9M
201775.9M78.0M78.6M80.4M
201671.5M73.4M74.5M74.5M
201569.2M69.1M68.7M70.0M
201469.9M68.5M69.7M69.1M
201340.1M49.1M56.5M64.5M
201200038.1M
20110000
20100000

Tracking the Latest Insider Buys and Sells of FONAR Corp

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Sep 30, 2022
damadian timothy raymond
bought
31,130
14.15
2,200
ceo, president & treasurer
Sep 30, 2022
bonanni luciano b
bought
48,144
14.16
3,400
exec vp, coo & pfo
Sep 29, 2022
damadian timothy raymond
bought
34,075
13.63
2,500
ceo, president & treasurer
Sep 29, 2022
bonanni luciano b
bought
17,966
13.82
1,300
exec vp, coo & pfo

1–4 of 4

Which funds bought or sold FONR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
unchanged
-
4,032
18,954
-%
Mar 11, 2024
VANGUARD GROUP INC
added
4.41
1,877,720
7,635,150
-%
Feb 15, 2024
JANE STREET GROUP, LLC
new
-
249,429
249,429
-%
Feb 15, 2024
BARCLAYS PLC
new
-
124,000
124,000
-%
Feb 14, 2024
Royal Bank of Canada
unchanged
-
62,000
291,000
-%
Feb 14, 2024
STATE STREET CORP
added
6.92
111,582
423,278
-%
Feb 14, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC
added
1.28
330,050
1,482,360
0.03%
Feb 14, 2024
RBF Capital, LLC
unchanged
-
303,921
1,429,010
0.09%

1–10 of 50

Are Funds Buying or Selling FONR?

Are funds buying FONR calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own FONR
No. of Funds

Unveiling FONAR Corp's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
renaissance technologies llc
4.70%
303,137
SC 13G/A
Feb 13, 2024
vanguard group inc
6.05%
390,345
SC 13G
Feb 13, 2024
kayne anderson rudnick investment management llc
9.81%
632,569
SC 13G/A
Feb 09, 2024
dimensional fund advisors lp
6.1%
394,759
SC 13G/A
Feb 14, 2023
kayne anderson rudnick investment management llc
9.63%
629,737
SC 13G/A
Feb 13, 2023
renaissance technologies llc
5.18%
338,416
SC 13G/A
Feb 10, 2023
dimensional fund advisors lp
6.0%
394,616
SC 13G/A
Feb 14, 2022
kayne anderson rudnick investment management llc
10.03%
657,067
SC 13G/A
Feb 11, 2022
renaissance technologies llc
6.17%
404,616
SC 13G/A
Feb 10, 2022
vanguard group inc
4.21%
275,763
SC 13G/A

Recent SEC filings of FONAR Corp

View All Filings
Date Filed Form Type Document
Feb 15, 2024
8-K
Current Report
Feb 14, 2024
10-Q
Quarterly Report
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 13, 2024
SC 13G/A
Major Ownership Report
Feb 13, 2024
SC 13G
Major Ownership Report
Feb 09, 2024
SC 13G/A
Major Ownership Report

Peers (Alternatives to FONAR Corp)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
184.1B
23.9B
1.92% 4.87%
38.82
7.71
-10.33% -33.23%
44.8B
3.7B
-4.47% 16.47%
53.05
12.25
8.72% 24.44%
43.2B
6.7B
9.35% 8.66%
34.96
6.42
-2.81% -6.58%
14.5B
9.3B
4.27% -4.49%
16.99
1.57
-6.38% -9.73%
13.8B
4.1B
11.27% 27.86%
29.14
3.35
3.86% -2.39%
12.4B
1.9B
4.38% 126.16%
43.86
6.58
29.17% 15.26%
12.1B
2.5B
1.85% -6.90%
-59.47
4.86
19.93% 67.26%
10.9B
1.1B
31.87% 65.38%
-25.12
10.09
31.99% 20.63%
MID-CAP
3.3B
918.7M
-13.78% -12.36%
284.21
3.64
45.66% 172.57%
2.2B
563.9M
-23.06% -38.26%
-4.56
3.88
25.45% 26.76%
SMALL-CAP
544.7M
280.3M
17.34% 2.80%
-2.86
1.94
-12.89% -148.37%
89.4M
31.2M
-3.36% -85.17%
-1.01
2.86
5.03% -1.81%
35.5M
9.2M
-24.43% -39.17%
-1.95
3.86
16.43% 46.89%
7.3M
9.0M
-21.88% -54.13%
-1.01
0.81
-53.31% 2.21%
183.8K
25.9M
-50.00% -94.83%
-0.01
0.01
-57.78% -93.11%

FONAR Corp News

Latest updates
MarketBeat • 24 Mar 2024 • 04:14 am
Quartz • 14 Feb 2024 • 08:00 am
StockNews.com • 9 months ago

FONAR Corp Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue-1.7%25.0026.0026.0025.0024.0023.0025.0025.0024.0024.0025.0023.0021.0021.0021.0022.0021.0022.0022.0023.0021.00
Costs and Expenses6.4%21.0019.0023.0021.0020.0019.0021.0019.0018.0018.0021.0019.0016.0017.0020.0019.0016.0016.0018.0016.0015.00
  S&GA Expenses14.8%6.005.009.007.007.006.008.006.005.005.008.006.005.006.0011.007.004.004.007.005.004.00
  R&D Expenses-10.9%0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.001.001.000.000.000.001.00
EBITDA Margin6.5%0.24*0.22*0.20*0.21*0.23*0.25*0.27*0.28*0.27*0.26*0.24*0.21*0.19*0.19*0.21*0.24*0.29*0.30*0.30*0.31*0.29*
Interest Expenses-79.2%0.000.00--0.000.00--0.000.000.000.000.000.000.000.000.000.000.000.00-0.02
Income Taxes-18.2%1.002.001.000.001.001.000.002.001.001.002.000.001.001.00-0.401.001.001.001.001.00-1.21
Earnings Before Taxes-14.9%6.007.003.005.004.004.004.006.007.007.004.004.005.004.001.003.005.006.004.007.006.00
EBT Margin7.9%0.20*0.18*0.16*0.17*0.19*0.21*0.23*0.24*0.23*0.22*0.20*0.16*0.15*0.15*0.17*0.20*0.24*0.26*0.26*0.27*0.25*
Net Income-8.5%4.004.001.004.002.002.002.002.004.004.001.004.003.003.001.001.003.003.005.004.004.00
Net Income Margin12.1%0.13*0.11*0.10*0.11*0.09*0.11*0.13*0.11*0.13*0.13*0.11*0.12*0.09*0.09*0.10*0.14*0.17*0.17*0.18*0.24*0.24*
Free Cashflow54.3%4.003.004.002.003.002.004.003.004.000.005.003.004.003.006.002.004.002.006.00-1.828.00
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22019Q2
Assets0.4%202202201199197198199196194188190187185183180134
  Current Assets2.6%13312912612212111911911411210910910410299.0096.0085.00
    Cash Equivalents3.0%53.0052.0051.0050.0050.0049.0049.0046.0045.0043.0044.0041.0041.0039.0037.0014.00
  Net PPE-4.7%20.0021.0022.0023.0022.0022.0022.0022.0022.0022.0022.0022.0022.0021.0021.0017.00
  Goodwill0%4.004.004.004.004.004.004.004.004.004.004.000.004.004.004.004.00
Liabilities-3.2%46.0047.0050.0049.0049.0051.0053.0051.0051.0049.0054.0050.0050.0053.0054.0015.00
  Current Liabilities-0.4%14.0014.0016.0014.0014.0015.0017.0014.0014.0016.0020.0017.0017.0019.0019.0014.00
  Long Term Debt-11.5%0.000.000.000.000.000.000.000.000.000.001.001.001.001.001.000.00
    LT Debt, Current0%0.000.000.000.00--0.00---------
    LT Debt, Non Current-11.5%0.000.000.000.00--0.00---------
Shareholder's Equity6.4%164154158157148147146148142139135135132128126118
  Retained Earnings18.7%-16.33-20.08-24.19-25.43-29.29-31.52-33.57-35.81-38.10-42.12-46.01-46.73-50.60-53.71-56.22-64.46
  Additional Paid-In Capital-1.1%181183183184184185185185185185185185185183183181
Shares Outstanding0.6%6.006.00-6.007.007.007.007.007.007.007.006.006.006.006.006.00
Minority Interest-5.0%-7.59-7.23-7.08-6.56-6.02-5.08-4.05-3.77-3.31-2.83-3.05-2.90-1.95-0.640.002.00
Float-----106---95.00---110---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations55.5%4,0712,6184,3184,2873,1652,6975,1844,3224,5541,2415,9483,5885,7703,7826,4713,7455,9444,2436,3163,4915,872
Cashflow From Investing-68.4%-133-79.00-698-2,204-473-963-766-1,723-1,481-1,209-646-1,940-1,798-435-96013,300-2,349-2,568-421-15,874-1,814
Cashflow From Financing-13.2%-2,406-2,126-1,980-1,948-1,883-1,761-1,705-1,440-1,627-1,087-1,650-1,418-2,156-1,386273-1,419-1,996-1,763-1,792-1,124-1,958
  Buy Backs64.0%1,171714510771356122---------------

FONR Income Statement

2023-12-31
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
REVENUES    
Patient fee revenue – net of contractual allowances and discounts$ 8,221$ 7,129$ 16,896$ 13,205
Product sales – net55170219200
Service and repair fees – net1,7781,8383,6433,658
Service and repair fees - related parties – net28285555
Management and other fees – net12,31612,09224,43624,342
Management and other fees - related medical practices – net2,9882,9995,9755,987
Total Revenues – Net25,38624,25651,22447,447
COSTS AND EXPENSES    
Costs related to patient fee revenue4,6024,0239,0297,822
Costs related to product sales302214405383
Costs related to service and repair fees7847221,6331,440
Costs related to service and repair fees - related parties12112522
Costs related to management and other fees7,2086,62214,23113,124
Costs related to management and other fees – related medical practices1,5901,4923,1092,890
Research and development416342883691
Selling, general and administrative5,5876,59810,45312,932
Total Costs and Expenses20,50120,02439,76839,304
Income From Operations4,8854,23211,4568,143
Other Income (Expense)(208)1(197)
Other Income – Related party577577
Interest Expense(10)(12)(58)(27)
Investment Income5342631,040414
Income Before Provision for Income Taxes and Non controlling Interests5,9864,27513,0168,333
Provision for Income Taxes(1,366)(1,463)(3,036)(2,871)
Net Income4,6202,8129,9805,462
Net Income – Non controlling Interests(861)(580)(2,115)(1,183)
Net Income – Attributable to FONAR$ 3,759$ 2,232$ 7,865$ 4,279

FONR Balance Sheet

2023-12-31
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Dec. 31, 2023
Jun. 30, 2023
Current Assets:  
 Cash and cash equivalents$ 53,225$ 51,280
 Short-term investments3333
 Accounts receivable – net3,8813,861
 Accounts receivable - related party60
 Medical receivable – net22,54821,259
 Management and other fees receivable – net39,35235,888
Management and other fees receivable – related medical practices – net9,2679,162
 Inventories2,8352,570
 Prepaid expenses and other current assets1,3411,608
Total Current Assets132,542125,661
Accounts receivable – long term376710
 Note receivable – related party577
 Deferred income tax asset7,75810,042
 Property and equipment – net20,10922,146
 Right-of-use Asset – operating lease32,23433,069
 Right-of-use Asset – financing lease630729
 Goodwill4,2694,269
 Other intangible assets – net3,2663,432
 Other assets501524
 Total Assets202,262200,582
Current Liabilities:  
Current portion of long-term debt4544
Accounts payable1,3351,579
Other current liabilities3,4605,444
 Unearned revenue on service contracts3,8043,832
 Unearned revenue on service contracts – related party55
 Operating lease liability - current portion4,6583,905
 Financing lease liability - current portion222218
Customer deposits600602
Total Current Liabilities14,17915,624
Long-Term Liabilities:  
 Unearned revenue on service contracts376760
 Deferred income tax liability395395
 Due to related medical practices9393
 Operating lease liability – net of current portion30,29932,105
 Financing lease liability – net of current portion508620
 Long-term debt, less current portion92115
 Other liabilities2342
Total Long-Term Liabilities31,78634,130
 Total Liabilities45,96549,754
 Paid-in capital in excess of par value180,607182,613
 Accumulated deficit(16,326)(24,191)
Treasury stock, at cost - 4 shares of common stock at December 31, 2023 and 11 shares of common stock at June 30, 2023(395)(516)
 Total Fonar Corporation’s Stockholders’ Equity163,887157,907
 Non controlling interests(7,590)(7,079)
 Total Stockholders’ Equity156,297150,828
 Total Liabilities and Stockholders’ Equity202,262200,582
Class A Non Voting Preferred Stock [Member]  
Long-Term Liabilities:  
Preferred stock value
Preferred Stock [Member]  
Long-Term Liabilities:  
Preferred stock value
Common Stock [Member]  
Long-Term Liabilities:  
Common stock value11
Common Class B [Member]  
Long-Term Liabilities:  
Common stock value
Common Class C [Member]  
Long-Term Liabilities:  
Common stock value
FONR
FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 41 MRI scanning facilities, including 26 facilities located in New York and 15 facilities located in Florida. The company markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.
 CEO
 WEBSITEwww.fonar.com
 EMPLOYEES484

FONAR Corp Frequently Asked Questions


What is the ticker symbol for FONAR Corp? What does FONR stand for in stocks?

FONR is the stock ticker symbol of FONAR Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of FONAR Corp (FONR)?

As of Wed Mar 27 2024, market cap of FONAR Corp is 140.5 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of FONR stock?

You can check FONR's fair value in chart for subscribers.

What is the fair value of FONR stock?

You can check FONR's fair value in chart for subscribers. The fair value of FONAR Corp is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of FONAR Corp is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for FONR so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is FONAR Corp a good stock to buy?

The fair value guage provides a quick view whether FONR is over valued or under valued. Whether FONAR Corp is cheap or expensive depends on the assumptions which impact FONAR Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for FONR.

What is FONAR Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Mar 27 2024, FONR's PE ratio (Price to Earnings) is 10.84 and Price to Sales (PS) ratio is 1.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. FONR PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on FONAR Corp's stock?

In the past 10 years, FONAR Corp has provided 0.015 (multiply by 100 for percentage) rate of return.